Directory

>

David Peritt

avatar

David Peritt

Consultant | Korro Bio, Inc.

Chicago, Illinois, United States

View contact details (it's free)

David Peritt

Summary

David Peritt is a seasoned expert in the field of biotechnology and immunology, specializing in the development of innovative therapeutic solutions, particularly in gene therapy and cell-based treatments. As the Founder and Chief Scientific Officer of Lupagen, he leads efforts to revolutionize bedside cell therapy with a focus on patient safety and cost efficiency. David's extensive experience includes leadership roles in renowned organizations such as Pfizer and Johnson & Johnson, where he contributed to groundbreaking advancements in CAR-T therapies and regenerative medicine. He is also an adjunct professor at Northwestern University, where he shares his expertise with the next generation of biotech professionals. With multiple patents and board memberships to his name, David is recognized as a thought leader in the biopharmaceutical industry. His passion for transforming healthcare through science is evident in his commitment to developing therapies that broaden access and improve patient outcomes.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

David Peritt

Work Experience

company logo

Consultant at

Guidepoint

January 2021 - Present

company logo

Scientific Advisory Board Member at

Korro Bio, Inc.

January 2021 - Present

company logo

Founder and CSO at

Lupagen

January 2017 - Present

company logo

Adjunct Professor at

Northwestern University

April 2015 - Present

company logo

Science & Technology Committee Member at

Alliance for Regenerative Medicine

January 2015 - Present

company logo

Chief Scientific Officer at

Sigilon Therapeutics, Inc.

June 2017 - April 2021

company logo

Program Lead, Tolerance and Cell Therapy at

Pfizer

February 2016 - May 2017

company logo

Biosimilars Biology and Immunology at

Hospira

January 2012 - January 2015

company logo

Strategic Corporate Investor, Cell Therapy and Regenerative Medicine at

Hospira

July 2008 - November 2011

company logo

Director at

Johnson & Johnson

January 2005 - January 2008

company logo

Head Of Research And Development at

Therakos

June 2001 - June 2007

company logo

Senior Research Scientist at

Centocor

January 1998 - January 2001

company logo

Graduate School at

University Of Pennsylvania

January 1992 - January 1998

company logo

Associate Scientist at

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company

January 1991 - January 1992

company logo

Graduate Student at

Hadassa Medical centers the hebrew university jerusalem

January 1988 - January 1991

company logo

Scientist at

US Army

January 1986 - January 1987

company logo

Research Intern at

USDA

January 1985 - January 1985

Logos provided by Logo.dev

David Peritt

Education

University of Pennsylvania, Doctor Of Philosophy (Ph.D.)

Hebrew University of Jerusalem, Master Of Science (Msc)

University of Maryland, Bachelor Of Science (B.Sc.)

Frequently Asked Questions about David Peritt

What is David Peritt email address?

David Peritt's primary email address is *******@korrobio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does David Peritt work for?

David Peritt is a Consultant at Korro Bio, Inc., a company specializing in Commercial physical research.

Where David Peritt graduated from?

David Peritt holds a degree in Immunology from University of Pennsylvania.

How can I directly contact David Peritt?

To contact David Peritt directly, you can use the email address *******@korrobio.com. Complete contact information is available upon registration with Muraena.

Who is David Peritt?

David Peritt is a seasoned expert in the field of biotechnology and immunology, specializing in the development of innovative therapeutic solutions, particularly in gene therapy and cell-based treatments. As the Founder and Chief Scientific Officer of Lupagen, he leads efforts to revolutionize bedside cell therapy with a focus on patient safety and cost efficiency. David's extensive experience includes leadership roles in renowned organizations such as Pfizer and Johnson & Johnson, where he contributed to groundbreaking advancements in CAR-T therapies and regenerative medicine. He is also an adjunct professor at Northwestern University, where he shares his expertise with the next generation of biotech professionals. With multiple patents and board memberships to his name, David is recognized as a thought leader in the biopharmaceutical industry. His passion for transforming healthcare through science is evident in his commitment to developing therapies that broaden access and improve patient outcomes.

David`s contact details

mail

*******@korrobio.com

************@lupagen.com

************@pfizer.com

************@sigilon.com

Colleagues

Paul Peng

VP, Head of CMC

avatar
Stephanie Engels

SVP, HR People & Culture

avatar
Ram Aiyar

Director Board of Directors

avatar
Derek Erion

Vice President

avatar
Todd Chappell

Senior Vice President, Strategy And Portfolio Planning

avatar
Mohammad Shadid

Vice President, Translational Sciences

avatar
Marco Passini

Vice President, Head of CNS Biology

avatar
Jayati Vaidya

Vice President, Corporate Strategy & Portfolio Planning

avatar
Venkat Krishnamurthy

Senior Vice President, Head of Platform Research - RNA Editing

avatar
Vineet Agarwal

Chief Financial Officer

View Contact details (it's free)
Request Profile Removal